<<
>>

. . .. - . .: , 2002: 57-59. .., . . - : , 1980: 76.
.. . ., 1986.

.., .. . , . , . 2003; 5(4): 342-353. .. - . . . . 2001; 3(2): 6-14. Akaike N., Harata N. Nystatin perforated patch recording and its applications to analyses of intracellular mechanisms. Jpn. J. Physiol. 1994; 44: 433-473. Arikan S., Rex J.H. Lipid-based antifungal agents: current status. Curr. Pharm. Des. 2001; 7: 393-415. Arning M., Kliche K.O., Heer-Sonderhoff A.H., Wehmeier A. Infusion-related toxicity of three different amphotericin formulations and its relation to cytokine plasma levels. Mycoses 1995; 38: 459-465. Baginski M., Czub J., Sternal K. Interaction of amphotericin and its selected derivatives with membranes: molecular modeling studies. Chem. Rec. 2006; 6: 320-332. Baginski M., Sternal K., Czub J., Borowski E. Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic. Acta Biochim. Pol. 2005; 52: 655-658. Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties. Biochim. Biophys. Acta 1986; 864: 257304. Ehrenfreund-Kleinman T., Domb A.J., Jaffe C.L. et al. The effect of amphotericin b derivatives on Leishmania and immune functions. J. Parasitol. 2005; 91: 158-163. Falk R., Hacham M., Nyska A. et al. Induction of interleukin-lbeta, tumour necrosis factor-alpha and apoptosis in mouse organs by amphotericin is neutralized by conjugation with arabinogalactan. J. Antimicrob. Chemother. 2005; 55: 713-720. Henry-Toulme N., Hermier B., Seman M. Im- munomodulating properties of the N-(l-de- oxy-D-fructos-lyl) derivative of amphotericin in mice.

Immunol. Lett. 1989; 20: 63-67. Henry-Toulme N., Sarthou P., Bolard J. Early membrane potential and cytoplasmic calcium changes during mitogenic stimulation of WEHI 231 cell line by polyene antibiotics,

lipopolysaccharide and anti-immunoglobulin. Biochim. Biophys. Acta 1990; 1051: 285292. Henry-Toulme N., Sarthou P., Seman M., Bolard J. Membrane effects of the polyene antibiotic amphotericin and of some of its derivatives on lymphocytes. Mol. Cell Bio- chem. 1989; 91: 39-44. Henry-Toulme N., Seman M., Bolard J. Interaction of amphotericin and its N-fruc- tosyl derivative with murine thymocytes: a comparative study using fluorescent membrane probes. Biochim. Biophys. Acta 1989; 982: 245-252. Hopfer R.L., Mehta R., Lopez-Berestein G.

Synergistic antifungal activity and reduced toxicity of liposomal amphotericin combined with gramicidin S or NF. Antimicrob. Agents Chemother. 1987; 31: 1978-1981. Kumar S., Chakrabarti R. Amphotericin both inhibits and enhances T-cell proliferation: inhibitory effect is mediated through H(2)0(2) production via cyclooxygenase pathway by macrophages. J. Cell Biochem. 2000; 77: 361-371. Little J.R., Abegg A., Plut E. The relationship between adjuvant and mitogenic effects of amphotericin methyl ester. Cell Immunol. 1983; 78: 224-235. Little J.R., Shore V. Modulation by lipoproteins of amphotericin -induced immunos- timulation. Cell Immunol. 1985; 93: 212-221. Lowery M.M., Greenberger P.A. Amphotericin-induced stridor: a review of stridor, amphotericin preparations, and their immu- noregulatory effects. Ann. Allergy Asthma Immunol. 2003; 91: 460-466. Rahman M.U., Mazumder A. The immunomodulatory effects of gentamicin, imipen- em, piperacillin and amphotericin on LAK effector function in vitro. FEMS Immunol. Med. Microbiol. 2001; 30: 249-252. Rama Iniguez S., Dea-Ayuela M.A., Sanchez-Brunete J.A. et al. Real-time reverse transcription-PCR quantification ofcytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin formulation.

Antimicrob. Agents Chemother. 2006; 50: 1195-1201. Sarthou P., Primi D., Cazenave P.A. cell triggering properties of a nontoxic derivative of amphotericin B. J. Immunol. 1986; 137: 2156-2161. Sau K., Mambula S.S., Latz E. et al. The antifungal drug amphotericin promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J. Biol. Chem. 2003; 278: 37561-37568. Shadkchan Y., Keisari V., Segal E. Cytokines in mice treated with amphotericin B-intra- lipid. Med. Mycol. 2004; 42: 123-128. Simitsopoulou M., Roil ides £., Dot is J. et al. Differential Expression of Cytokines and Chemokines in Human Monocytes Induced by Lipid Formulations of Amphotericin B. Antimicrob. Agents Chemother. 2005; 49: 1397-1403. Stein S.H., Little J.R., Little K.D. Parallel inheritance of tissue catalase activity and im- munostimulatory action of amphotericin in inbred mouse strains. Cell Immunol. 1987; 105: 99-109. Tokuda Y., Tsuji M., Yamazaki M. et al. Augmentation of murine tumor necrosis factor production by amphotericin in vitro and in vivo. Antimicrob. Agents Chemother. 1993; 37: 2228-2230. Vonk A.G., Netea M.G., Denecker N.E. et

al. Modulation of the pro- and anti-inflammatory cytokine balance by amphotericin B. J. Antimicrob. Chemother. 1998; 42: 469-474. Wolf J.E., Stein S.H., Little K.D. et al. Amphotericin selectively stimulates macrophages from high responder mouse strains. Immunopharmacol. Immunotoxicol. 1991; 13: 221-235. Yamaguchi H., Abe S., Tokuda Y. Immuno- modulating activity of antifungal drugs. Ann.

N.Y. Acad. Sci. 1993; 685: 447-457.

r

-\

<< | >>
: .. , .. , .. . 2012. 2012

:

- - - -
- - - - - - - - - - - - - -